SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The Use of Flexible Manufacturing Capacity in Pharmaceutical Product Introductions*
16 references·2 citing·40 second hop
The Use of Flexible Manufacturing Capacity in Pharmaceutical Product Introductions* (2009)The Use of Flexible Manufacturing Capacit…Estimating The Cost Of New Drug Development: Is It Really $802 Million? (2006)Estimating The Cost Of New Dr…Optimal Investment Strategies for Flexible Resources, Considering Pricing and Correlated Demands (2004)Optimal Investment Strategies…The price of innovation: new estimates of drug development costs (2003)The price of innovation: new …Process Flexibility in Supply Chains (2003)Process Flexibility in Supply…Commissioned Paper: Capacity Management, Investment, and Hedging: Review and Recent Developments (2003)Commissioned Paper: Capacity …Returns on Research and Development for 1990s New Drug Introductions (2002)Returns on Research and Devel…Risks in new drug development: Approval success rates for investigational drugs (2001)Risks in new drug development…Investment Strategies for Flexible Resources (1998)Investment Strategies for Fle…The development factory: Unlocking the potential of process innovation (1997)The development factory: Unlo…Competitive Markov Decision Processes (1996)Competitive Markov Decision P…Success rates for new drugs entering clinical testing in the United States (1995)Success rates for new drugs e…Principles on the Benefits of Manufacturing Process Flexibility (1995)Principles on the Benefits of…Returns to R&D on new drug introductions in the 1980s (1994)Returns to R&D on new drug in…Investment under Uncertainty (1994)Investment under UncertaintyPricing, Profits, and Technological Progress in the Pharmaceutical Industry (1993)Pricing, Profits, and Technol…A New Look at the Returns and Risks to Pharmaceutical R&D (1990)A New Look at the Returns and…An Integrative approach to supply chain disruption risk and resilience management: a literature review (2020)An Integrative approach to su…Utilizing customer knowledge in innovation: antecedents and impact of customer involvement on new product performance (2015)Utilizing customer knowledge …Discounted Stochastic Games (1998)Game Theory in Supply Chain Analysis (2004)Action understanding as inverse planning (2009)Multiagent systems: algorithmic, game-theoretic, and logical foundations (2009)Cost of innovation in the pharmaceutical industry (1991)Deconstructing the Drug Development Process: The New Face of Innovation (2010)Clinical development success rates for investigational drugs (2014)Optimal Investment in Product-Flexible Manufacturing Capacity (1990)Manufacturing Flexibility: A Strategic Perspective (1993)A supply chain view of the resilient enterprise (2005)On the Value of Mitigation and Contingency Strategies for Managing Supply Chain Disruption Risks (2006)Exploration and Exploitation in Organizational Learning (1991)Dynamic capabilities and strategic management (1997)Common method biases in behavioral research: A critical review of the literature and recommended remedies. (2003)S-D logic–informed customer engagement: integrative framework, revised fundamental propositions, and application to CRM (2016)Toward a theory of customer engagement marketing (2016)Digital transformation: A multidisciplinary reflection and research agenda (2019)Stocks, bonds, bills, and inflation yearbook (1993)Can the pharmaceutical industry reduce attrition rates? (2004)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery (1996)Tolerance for Failure and Corporate Innovation (2011)Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018 (2020)Towards a Methodology for Developing Evidence‐Informed Management Knowledge by Means of Systematic Review (2003)A framework of sustainable supply chain management: moving toward new theory (2008)From a literature review to a conceptual framework for sustainable supply chain management (2008)COVID-19 pandemic related supply chain studies: A systematic review (2021)Thriving, Not Just Surviving in Changing Times: How Sustainability, Agility and Digitalization Intertwine with Organizational Resilience (2021)Impact of supply chain digitalization on supply chain resilience and performance: A multi-mediation model (2023)The Economics of Modern Manufacturing: Technology, Strategy, and Organization (1990)Investment Under Uncertainty. (1994)Monotone Comparative Statics (1994)Risk Ownership in Contract Manufacturing (2007)Optimum consumption and portfolio rules in a continuous-time model (1971)Supply Chain Management Research and Production and Operations Management : Review, Trends, and Opportunities (2006)The design of robust value-creating supply chain networks: A critical review (2009)Technology Choice and Capacity Portfolios under Emissions Regulation (2015)Capital markets research in accounting (2001)Policy Uncertainty and Corporate Investment (2015)Measuring Economic Policy Uncertainty* (2016)
this work references cited by second hop

References

  • 1994Investment under Uncertainty9,092 cited
  • 2003The price of innovation: new estimates of drug development costs4,312 cited
  • 1996Competitive Markov Decision Processes1,169 cited
  • 2006Estimating The Cost Of New Drug Development: Is It Really $802 Million?906 cited
  • 1995Principles on the Benefits of Manufacturing Process Flexibility827 cited
  • 2003Commissioned Paper: Capacity Management, Investment, and Hedging: Review and Recent Developments568 cited
  • 2001Risks in new drug development: Approval success rates for investigational drugs450 cited
  • 1998Investment Strategies for Flexible Resources351 cited
  • 2003Process Flexibility in Supply Chains320 cited
  • 2002Returns on Research and Development for 1990s New Drug Introductions311 cited
  • 1997The development factory: Unlocking the potential of process innovation286 cited
  • 1990A New Look at the Returns and Risks to Pharmaceutical R&D286 cited
  • 1993Pricing, Profits, and Technological Progress in the Pharmaceutical Industry255 cited
  • 1994Returns to R&D on new drug introductions in the 1980s197 cited
  • 1995Success rates for new drugs entering clinical testing in the United States184 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2004Optimal Investment Strategies for Flexible Resources, Considering Pricing and Correlated Demands133 cited
  • Cited by

    • 2015Utilizing customer knowledge in innovation: antecedents and impact of customer involvement on new product performance533 cited
    • 2020An Integrative approach to supply chain disruption risk and resilience management: a literature review335 cited